MALFITANO, Anna Maria
 Distribuzione geografica
Continente #
NA - Nord America 1.286
EU - Europa 489
AS - Asia 145
AF - Africa 7
SA - Sud America 5
Totale 1.932
Nazione #
US - Stati Uniti d'America 1.269
IT - Italia 251
CN - Cina 96
NL - Olanda 52
GB - Regno Unito 44
UA - Ucraina 30
IN - India 26
DE - Germania 25
SE - Svezia 24
IE - Irlanda 20
CA - Canada 16
FI - Finlandia 15
VN - Vietnam 12
CI - Costa d'Avorio 7
ES - Italia 7
FR - Francia 7
BR - Brasile 5
CZ - Repubblica Ceca 5
SG - Singapore 4
BG - Bulgaria 3
HK - Hong Kong 2
HU - Ungheria 2
IR - Iran 2
CH - Svizzera 1
IL - Israele 1
LU - Lussemburgo 1
MY - Malesia 1
PA - Panama 1
PL - Polonia 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 1.932
Città #
Chandler 353
Naples 87
Millbury 82
Ashburn 76
Lawrence 57
Amsterdam 48
Boston 39
Napoli 38
Des Moines 36
Beijing 32
Wilmington 30
Nanjing 22
Rome 20
Princeton 17
Jacksonville 16
Ottawa 13
Dong Ket 12
Hebei 11
Ann Arbor 10
Washington 9
Nanchang 7
Pune 7
Changsha 6
Jiaxing 6
Augusta 5
Norwalk 5
Dublin 4
Fairfield 4
Letovice 4
Madrid 4
New Delhi 4
Nijmegen 4
Rio Grande 4
San Mateo 4
Seattle 4
Boardman 3
Cagliari 3
Giugliano In Campania 3
Linköping 3
Modena 3
Redwood City 3
Sofia 3
Tianjin 3
Treviso 3
Woodbridge 3
Ardabil 2
Arezzo 2
Barcelona 2
Baronissi 2
Budapest 2
Chatsworth 2
Columbus 2
Ercolano 2
Falls Church 2
Florence 2
Hong Kong 2
Houston 2
Kronberg 2
Los Angeles 2
Marigliano 2
Munich 2
Padova 2
Paris 2
Romainville 2
Salerno 2
Shanghai 2
Shenyang 2
Afragola 1
Atlanta 1
Bialystok 1
Capaccio 1
Casoria 1
Changchun 1
Clearwater 1
Dallas 1
Dearborn 1
Esslingen am Neckar 1
Farnborough 1
Ferrara 1
Frankfurt am Main 1
Frattaminore 1
Fuzhou 1
Gesualdo 1
Greenwich 1
Hangzhou 1
Helsinki 1
Herrischried 1
Indiana 1
Islington 1
Khon Kaen 1
Kuala Lumpur 1
La Canada Flintridge 1
Leawood 1
Marano Di Napoli 1
Massa 1
Milan 1
Montemiletto 1
Montreal 1
Mumbai 1
Nashville 1
Totale 1.187
Nome #
Endocannabinoid System in Neurological Disorders 66
Nucleophosmin-1 regions associated with acute myeloid leukemia interact differently with lipid membranes 58
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism 54
Anandamide inhibits adhesion and migration of breast cancer cells. 54
Cannabidiol: State of the art and new challenges for therapeutic applications 53
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 52
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 48
Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia 47
G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer Cells 44
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. 42
A comparative study of the effects of platinum (Ii) complexes on β-amyloid aggregation: Potential neurodrug applications 42
p53 regulates the mevalonate pathway in human glioblastoma multiforme 41
Anandamide inhibits endothelial cell proliferation in vitro and angiogenesis in vivo 41
Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces 36
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis 36
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 36
Glucosyl Platinum(II) Complexes Inhibit Aggregation of the C-Terminal Region of the Aβ Peptide 35
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives 34
Breast adiponcosis: a call for further research 33
ONCOLYTIC VIRUSES AS A POSSIBLETHERAPEUTIC STRATEGY AGANIST MALIGNANT PLEURAL MESOTHELIOMA 33
Comment on “the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.” 32
What we know and do not know about the cannabinoid receptor 2 (CB2) 32
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response 31
Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model Systems 31
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 31
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 29
The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway 29
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth 29
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug 28
Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa 28
The oncolytic virus dl922-947 triggers immunogenic cell death in mesothelioma and reduces Xenograft growth 28
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells 28
Reply to comment on “Malfitano, A.M. et al. virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer” cancers 2019, 11, 1532 28
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2’,3’-cyclic nucleotide-3’-phosphodiesterase 27
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 26
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer" 25
Statins in neurological disorders: an overview and update 25
Pharmacological inhibition of wee1 potentiates the antitumoral effect of the dl922-947 oncolytic virus in malignant mesothelioma cell lines 25
Virotherapy: From single agents to combinatorial treatments 24
Cannabinoid receptor CB1 antagonists state of the art and challenges 23
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 23
Pharmacological actions of statins: A critical appraisal in the management of cancer 23
Self-assembly of bio-inspired heterochiral peptides 23
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells 22
Cannabinoids in the management of spasticity associated with multiple sclerosis 22
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold 21
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation 21
Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia 21
Combination of dl922-947 Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast Cancer 21
Proteostasis unbalance of nucleophosmin 1 in Acute Myeloid Leukemia: An aggregomic perspective 20
The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach. 20
Phytocannabinoids and cannabimimetic drugs: Recent patents in central nervous system disorders 19
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells 18
Endocannabinoids in endocrine and related tumours 18
Tumor-associated macrophage status in cancer treatment 18
Targeting G-quadruplex motifs interferes with differentiation of adipose-derived mesenchymal stem cells 18
History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic viruses 17
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 17
Virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer 17
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 17
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 17
Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis 17
Update on the endocannabinoid system as an anticancer target 17
Inhibition of HMG-CoA reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cell. 16
Interactions of cisplatin analogues with lysozyme: a comparative analysis 16
Cross talk of macrophages with tumor microenvironment cells and modulation of macrophages in cancer by virotherapy 16
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A. 15
Molecular signaling involving intrinsically disordered proteins in prostate cancer 14
Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia 13
Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1 12
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice 12
From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches 12
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 12
Potential therapeutic role of statins in neurological disorders 12
Immunological signature of patients with thymic epithelial tumors and Good syndrome 12
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 10
Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders) 10
Oxylipins from Dracontium loretense 9
The N-Terminal Domain of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Harbors a GTP/ATP Binding Site 7
From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases 6
Helicobacter pylori has stimulatory effects on naive T cells 6
Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells 5
Metal-Complexes Bearing Releasable CO Differently Modulate Amyloid Aggregation 3
Totale 2.109
Categoria #
all - tutte 9.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.061


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 2 3 3
2019/2020145 59 4 5 1 13 3 1 3 3 18 26 9
2020/2021150 3 7 13 4 12 13 31 15 4 4 24 20
2021/2022530 6 2 2 3 2 18 13 19 53 100 123 189
2022/2023737 89 103 6 74 93 75 1 72 129 47 42 6
2023/2024377 12 80 119 33 27 60 9 19 5 13 0 0
Totale 2.109